Elekta appoints Niklas Savander as its next President and Chief Executive Officer

  Elekta appoints Niklas Savander as its next President and Chief Executive
                                   Officer

PR Newswire

STOCKHOLM, Oct. 25, 2013

STOCKHOLM, Oct. 25, 2013 /PRNewswire/ --Elekta announced today that Niklas
Savander has been appointed as its next President and Chief Executive Officer,
effective May 1, 2014. Niklas Savander will succeed Tomas Puusepp, who will
continue with Elekta as a working member of its Board of Directors per the
same date.

(Photo: http://photos.prnewswire.com/prnh/20131025/CL04205)

Niklas Savander has extensive experience from senior management positions both
within Hewlett Packard and Nokia, most recently as a member of Nokia's
Executive Management Team responsible for the Company's day-to-day operations.
He is currently a Private Equity Adviser in Helsinki, Stockholm and London.
Mr. Savander is married and has two children.

Laurent Leksell, Elekta's founder, former CEO and Chairman of the Board of
Directors, commented: "We are very pleased to have been able to appoint such
an experienced and capable executive as Niklas Savander. His deep
understanding of complex global technology industries, as well as his
experience from global markets, is uniquely suited to lead Elekta through our
next phase of profitable growth."

Commenting on Tomas Puusepp, Laurent Leksell said: "Tomas Puusepp has done a
more than outstanding job as CEO. Under his leadership, Elekta has become a
full-service Radiation Therapy company with the ambition to become the market
leader in the next couple of years. I am pleased that Tomas has decided to
continue working for Elekta as full-time member of the Board of Directors."

Niklas Savander commented: "I feel honored. Elekta is a remarkable company:
innovative, well-managed and fast-growing. I am excited about the opportunity,
knowing what difference this company makes in the lives of people with
cancer."

Mr. Savander will join Elekta on January 1^st 2014 in order to prepare himself
for his new role. He will start as Elekta's President and CEO effective May
1^st 2014.

For further information, please contact:

Gert van Santen, Group Vice President Corporate Communications, Elekta AB

Tel: +31653561242, e-mail gert.vansanten@elekta.com



Johan Andersson, Director, Investor Relations, Elekta AB

Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com

Time zone: CET: Central European Time

The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 7:30 CET on October 25, 2013.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow
enhancing software systems across the spectrum of cancer care. Stretching the
boundaries of science and technology, providing intelligent and
resource-efficient solutions that offer confidence to both healthcare
providers and patients, Elekta aims to improve, prolong and even save patient
lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,500 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

SOURCE Elekta

Website: http://www.elekta.com
 
Press spacebar to pause and continue. Press esc to stop.